• Bowie A. & O'Neill L. A. (2000) Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59, 1323.DOI: 10.1016/s0006-2952(99)00296-8
  • Chang H. K., Gallo R. C., Ensoli B. (1995) Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed Sci. 2, 189202.
  • Christman J. W., Blackwell T. S., Juurlink B. H. (2000) Redox regulation of nuclear factor κB: therapeutic potential for attenuating inflammatory responses. Brain Pathol 10, 153162.
  • Demarchi F., D'Adda Di Fagagna F., Falaschi A., Giacca M. (1996) Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70, 44274437.
  • Demarchi F., Gutierrez M. I., Giacca M. (1999) Human immunodeficiency virus type 1 tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 73, 70807086.
  • Flores S. C., Marecki J. C., Harper K. P., Bose S. K., Nelson S. K., McCord J. M. (1993) Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl Acad. Sci. USA 90, 76327636.
  • Greco A., Minghetti L., Sette G., Fieschi C., Levi G. (1999) Cerebrospinal fluid isoprostane shows oxidative stress in multiple sclerosis patients. Neurology 53, 18761879.
  • Jones M., Olafson K., Del Bigio M. R., Peeling J., Nath A. (1998) Intraventricular injection of Human immunodeficiency virus type 1 Tat protein causes inflammation, gliosis, apoptosis and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57, 563570.
  • Kolson D. L. & Gonzalez-Scarano F. (2000) HIV and HIV dementia. J. Clin. Invest. 106, 1113.
  • Lachgar A., Sojic N., Arbault S., Bruce D., Sarasin A., Amatore C., Bizzini B., Zagury D., Vuillaume M. (1999) Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteins. J. Virol. 73, 14471452.
  • Lawson J. A., Rokach J., Fitzgerald G. A. (1999) Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem. 274, 2444124444.
  • Marzio G., Tyagi M., Gutierrez M. I., Giacca M. (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl Acad. Sci. USA 95, 1351913524.
  • Minghetti L., Polazzi E., Nicolini A., Créminon C., Levi G. (1996) IFN-γ and nitric oxide down-regulate LPS-induced production in cultured rat microglial cells. J. Neurochem. 66, 19631970.
  • Nath A. & Geiger J. (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54, 1933.DOI: 10.1016/s0301-0082(97)00053-1
  • Nath A., Conant K., Chen P., Scott C., Major E. O. (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. J. Biol. Chem 274, 1709817102.DOI: 10.1074/jbc.274.24.17098
  • Patrizio M., Colucci M., Levi G. (2001) Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglial cells. J. Neurochem. 77, 399407.DOI: 10.1046/j.1471-4159.2001.00249.x
  • Polazzi E., Levi G., Minghetti L. (1999) Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J. Neuropathol. Exp. Neurol. 58, 825831.
  • Sheng W. S., Hu S., Hegg C. C., Thayer S. A., Peterson P. K. (2000) Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin. Immunol. 96, 243251.
  • Visentin S., Renzi M., Levi G. (2001) Altered outward-rectifying K+ current reveals microglial activation by HIV-1 Tat protein. Glia 33, 319325.